V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002503 | 250008668 | 1.68 | 88.3 | null | 2020-08-09 | 2020-08-09 | Oxaliplatin + Modified de Gramont | 02 | Y | TRIAL UNSPECIFIED | 101081853 |
| 250002505 | 250008669 | null | null | Curative (C) | 2020-04-19 | 2020-04-26 | Etoposide oral | N | N | CETUXIMAB | 100572530 |
| 250002509 | 250008671 | null | null | null | 2020-02-05 | 2020-02-06 | Trabectedin | 02 | N | CISPLATIN + RT | 100413560 |
| 250002512 | 250008672 | 1.69 | 70 | Palliative (P) | 2019-10-16 | 2019-10-16 | CAPECITABINE + OXALIPLATIN | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101653937 |
| 250002515 | 250008673 | 1.75 | 116.05 | null | 2019-04-01 | 2019-04-04 | Doxorubicin + Olaratumab | 02 | null | CAPECITABINE + OXALIPLATIN | 101254913 |
| 250002525 | 250008676 | null | null | Palliative (P) | 2021-12-22 | 2021-12-28 | NB HRNBL-1 COJEC Ind COURSE A | N | N | PACLITAXEL | 100606801 |
| 250002529 | 250008677 | 1.49 | 70 | null | null | 2019-10-31 | CARBOPLATIN + RT | null | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100323076 |
| 250002533 | 250008679 | 1.5 | 61 | Curative (C) | 2018-12-28 | 2018-12-30 | null | 02 | N | CEMIPLIMAB | 101026923 |
| 250002537 | 250008680 | 1.54 | 114 | Palliative (P) | null | 2019-11-28 | CAPECITABINE + OXALIPLATIN | null | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100221084 |
| 250002541 | 250008681 | null | null | Palliative (P) | null | 2019-12-20 | PACLITAXEL | null | Y | ATEZOLIZUMAB | 100870402 |
| 250000648 | 250008685 | 1.58 | 87.4 | Neo-adjuvant (N) | null | 2018-09-10 | NB HRNBL-1 Isotretinoin | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100068845 |
| 250000744 | 250008687 | null | null | null | 2020-04-25 | 2020-05-09 | null | N | null | DINUTUXIMAB BETA | 101856875 |
| 250000769 | 250008689 | 1.54 | 88 | null | 2022-01-12 | 2022-01-18 | null | 02 | N | IMATINIB | 101062710 |
| 250000823 | 250008692 | null | null | Palliative (P) | 2020-02-24 | 2020-03-14 | Trabectedin | 02 | Y | NIRAPARIB | 100791807 |
| 250000920 | 250008693 | 1.65 | 59.6 | Palliative (P) | 2018-08-30 | 2018-10-09 | null | 02 | null | NB HRNBL-1 COJEC IND COURSE C | 100989360 |
| 250001057 | 250008695 | null | null | null | null | 2020-03-23 | Carboplatin + Pemetrexed | null | null | CAPECITABINE + IRINOTECAN | 101410777 |
| 250001115 | 250008698 | 1.66 | 71.7 | Curative (C) | null | 2021-02-13 | null | 02 | N | PACLITAXEL | 101513283 |
| 250001208 | 250008701 | null | null | null | null | 2019-10-26 | Dinutuximab Beta | 02 | N | ERLOTINIB | 101544258 |
| 250001358 | 250008703 | 1.84 | 106 | Palliative (P) | 2019-04-30 | 2019-09-22 | Atezolizumab | 02 | N | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 100992873 |
| 250001677 | 250008706 | 1.7 | 70.4 | Neo-adjuvant (N) | null | 2020-06-16 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN | 100034115 |
| 250001793 | 250008708 | null | null | Palliative (P) | null | 2021-04-16 | Fluorouricil + Folonic Acid (MdG) | 02 | N | MIFAMURTIDE | 100602541 |
| 250001811 | 250008709 | 1.64 | 90.9 | null | 2021-04-07 | 2022-01-16 | ECX | 02 | null | DOXORUBICIN + IFOSFAMIDE | 100389389 |
| 250001892 | 250008710 | 1.71 | 59.1 | Palliative (P) | null | 2020-10-16 | Irinotecan + Modified De Gramont | 02 | N | BACILLUS CALMETTE-GUERIN | 101074705 |
| 250002014 | 250008711 | 1.87 | 48.5 | Palliative (P) | 2020-06-28 | 2020-06-28 | null | 02 | N | TIVOZANIB | 100115437 |
| 250002275 | 250008714 | null | null | null | null | 2019-08-12 | Carboplatin + Pemetrexed | null | N | FLUOROURACIL + MITOMYCIN + RT | 100548739 |
| 250002352 | 250008715 | null | null | Palliative (P) | null | 2020-01-26 | Cetuximab + Radiotherapy Maint | 01 | N | FLUOROURACIL + IRINOTECAN | 100092336 |
| 250001320 | 250008716 | null | null | null | null | 2018-01-27 | Fluorouracil+Mitomycin+RT (Bladder) | null | null | NB HRNBL- 1 DINUTUXIMAB/ ISOTRETONOIN | 100015616 |
| 250002073 | 250008719 | 1.71 | 50.4 | Curative (C) | 2020-03-22 | 2020-04-13 | DOXORUBICIN | 02 | N | PACLITAXEL | 101020099 |
| 250001271 | 250008783 | null | 111.3 | null | null | 2018-09-09 | CISPLATIN + GEMCITABINE | null | null | NIVOLUMAB | 101775036 |
| 250001273 | 250008784 | 1.75 | 74 | null | null | 2020-10-15 | null | null | null | NIVOLUMAB | 100844679 |
| 250001279 | 250008785 | 1.79 | 58 | null | null | 2019-10-10 | null | null | null | CISPLATIN + GEMCITABINE | 101831716 |
| 250001292 | 250008786 | 1.6 | 83 | Palliative (P) | 2017-10-04 | 2017-10-13 | null | 02 | null | CARBOPLATIN + GEMCITABINE | 100620150 |
| 250001320 | 250008787 | 1.73 | 68.5 | null | null | 2018-02-06 | GemCarbo Days 1+8 | null | null | CARBOPLATIN + GEMCITABINE | 100015616 |
| 250001322 | 250008788 | 1.66 | 104.5 | Palliative (P) | 2021-06-25 | 2021-06-26 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100804895 |
| 250001355 | 250008791 | 1.83 | 71 | null | null | 2021-08-13 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100649832 |
| 250001391 | 250008792 | 1.88 | null | null | null | 2021-10-30 | null | null | null | NIVOLUMAB | 100448194 |
| 250001393 | 250008793 | 1.78 | 77 | null | null | 2019-10-06 | CISPLATIN + GEMCITABINE | null | null | NIVOLUMAB | 101442283 |
| 250001440 | 250008795 | 1.82 | null | null | null | 2020-04-13 | GEMCARBO | null | null | CARBOPLATIN + GEMCITABINE | 101562981 |
| 250001449 | 250008796 | 1.58 | 85.3 | null | null | 2019-07-05 | null | null | null | PEMBROLIZUMAB | 101088329 |
| 250001545 | 250008798 | 1.69 | 105 | null | 2022-01-27 | 2022-02-06 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 100199934 |
| 250001558 | 250008799 | 1.6 | 57.1 | null | null | 2018-04-29 | CISPLATIN + GEMCITABINE | null | null | NIVOLUMAB | 101773875 |
| 250001596 | 250008800 | 1.69 | 45.1 | null | null | 2019-11-08 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100349637 |
| 250001623 | 250008801 | 1.71 | 87 | Palliative (P) | 2016-12-28 | 2017-07-09 | null | 02 | N | CARBOPLATIN + GEMCITABINE | 100527017 |
| 250001639 | 250008802 | 1.54 | null | null | null | 2019-06-13 | null | null | null | CISPLATIN + GEMCITABINE | 101341015 |
| 250001654 | 250008803 | null | 80 | null | null | 2017-01-15 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101137929 |
| 250001655 | 250008804 | 1.66 | null | null | null | 2019-09-08 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100492913 |
| 250001674 | 250008805 | 1.63 | null | null | 2017-02-21 | 2017-03-20 | CISPLATIN + GEMCITABINE | 02 | null | CISPLATIN + GEMCITABINE | 101494040 |
| 250001680 | 250008806 | null | 78.5 | Disease modification (D) | 2018-08-24 | 2018-09-06 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101211758 |
| 250001695 | 250008808 | 1.58 | 53.4 | null | null | 2019-04-01 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101389877 |
| 250001716 | 250008809 | 1.68 | 93.9 | null | 2019-04-13 | 2019-04-20 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101083089 |